Trials / Withdrawn
WithdrawnNCT02371798
Unilateral Meniere Disease: Can Double Dose Gadolinium and Delayed Imaging Make the Diagnosis?
Diagnosing Endolymphatic Hydrops in Patients With Meniere Disease Using Magnetic Resonance Imaging With Intravenous Gadolinium Administration
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Emory University · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this research study is to see if magnetic resonance imaging (MRI) with a double dose of contrast, or dye, and delayed imaging with MRI can help to diagnose Meniere Disease.
Detailed description
Meniere's disease (MD) is a medical condition causing attacks of vertigo, ringing in the ears, hearing loss and often a fullness in the ear. Currently there is no definitive test to diagnose the problem. It is believed to be caused by inner ear abnormalities, specifically of an over-collection of lymphatic fluid.The goal of this trial is to determine if an MRI with double dose of IV gadolinium can be diagnostic.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Gadopentetate dimeglumine | IV administration of 0.2 mmol/kg of Gd-DTPA |
Timeline
- Start date
- 2015-02-01
- Primary completion
- 2016-11-01
- Completion
- 2016-11-01
- First posted
- 2015-02-26
- Last updated
- 2016-12-01
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02371798. Inclusion in this directory is not an endorsement.